VOXZOGO

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Japan, Lithuania, Poland, Romania, Spain.

Active ingredients

The drug VOXZOGO contains one active pharmaceutical ingredient (API):

1
UNII 7SE5582Q2P - VOSORITIDE
 

Vosoritide is a modified type C natriuretic peptide (CNP). In patients with achondroplasia, endochondral bone growth is negatively regulated due to a gain of function mutation in fibroblast growth factor receptor 3 (FGFR3). Binding of vosoritide to natriuretic peptide receptor-B (NPR-B) antagonises FGFR3 downstream signalling by inhibiting the extracellular signal-regulated kinases 1 and 2 (ERK1/2) in the mitogen-activated protein kinase (MAPK) pathway at the level of rapidly accelerating fibrosarcoma serine/threonine protein kinase (RAF-1). As a result, vosoritide, like CNP, acts as a positive regulator of endochondral bone growth as it promotes chondrocyte proliferation and differentiation.

 
Read more about Vosoritide

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 VOXZOGO Powder and solvent for solution for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M05BX07 M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BX Other drugs affecting bone structure and mineralization
Discover more medicines within M05BX07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1861152, 1861163, 1861174
ES Centro de información online de medicamentos de la AEMPS 1211577001, 1211577002, 1211577003
FR Base de données publique des médicaments 60787186, 64530919, 68092884
IT Agenzia del Farmaco 049692015, 049692027, 049692039
JP 医薬品医療機器総合機構 3999465D1028, 3999465D2024, 3999465D3020
LT Valstybinė vaistų kontrolės tarnyba 1093281, 1093282, 1093283
PL Rejestru Produktów Leczniczych 100457685, 100457692, 100457712
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W68898001, W68899001, W68900001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.